Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy

In patients with Charcot–Marie–Tooth disease 1A (CMT1A), peripheral nerves display aberrant myelination during postnatal development, followed by slowly progressive demyelination and axonal loss during adult life. Here, we show that myelinating Schwann cells in a rat model of CMT1A exhibit a develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Fledrich, R., Abdelaal, T., Rasch, L., Bansal, V., Schütza, V., Brügger, B., Lüchtenborg, C., Prukop, T., Stenzel, J., Rahman, R. U., Hermes, D., Ewers, D., Möbius, W., Ruhwedel, T., Katona, I., Weis, J., Klein, D., Martini, R., Brück, W., Müller, W. C., Bonn, S., Bechmann, I., Nave, K. A., Stassart, R. M., Sereda, M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072747/
https://www.ncbi.nlm.nih.gov/pubmed/30072689
http://dx.doi.org/10.1038/s41467-018-05420-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072747/
https://www.ncbi.nlm.nih.gov/pubmed/30072689
http://dx.doi.org/10.1038/s41467-018-05420-0

Ejemplares similares